You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 9, September 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cytokine Expression in Otitis Media With Effusion

Tumor Necrosis Factor Soluble Receptor

Kenneth Maxwell, MD; Gerald Leonard, MD; Donald L. Kreutzer, PhD

Arch Otolaryngol Head Neck Surg. 1997;123(9):984-988.


Abstract

Background
A variety of cytokines, such as interleukin 1 and tumor necrosis factor (TNF), appear to play a key role in the initiation and maintenance of the inflammatory response in a variety of diseases, including chronic otitis media with effusion (COME). Recently, cytokine inhibitors have been isolated and are presumed to regulate the proinflammatory effects of these cytokines. This has lead us to hypothesize that the chronic inflammation seen in COME is the result of an imbalance in the ratio of proinflammatory cytokines and inhibitors that favors the proinflammatory cytokines.

Design
Middle ear effusions were evaluated for the cytokine TNF-{alpha} and the inhibitor TNF soluble receptor (TNFsolR) using a combination of enzyme-linked immunosorbent assays and radioactive immunoassays. We determined the presence and quantified the amounts of TNF-{alpha} and TNFsolR and correlated this result with Clinical parameters in patients with COME.

Setting
University hospital.

Patients
To test this hypothesis, 35 middle ear effusions were obtained from 29 children aged 2 to 102 months (mean, 39.6 months) undergoing tympanostomy tube insertion for COME.

Outcome
Children were followed up for at least 12 months postoperatively and the number of subsequent episodes of otitis media correlated with cytokine levels.

Results
The TNF-{alpha} and TNFsolR were present in 83% and 91% of effusions, respectively. The TNF-{alpha} mean (±SEM) cytokine values were 110.6±32.1 pg/mg of total protein, and 12 886±3108 pg/mg total protein for TNFsolR. Analysis of correlations in a univariate model revealed a statistically significant relationship for TNF-{alpha} correlated with TNFsolR (R2=0.463; P<.001). The TNF-{alpha} levels were significantly lower for children with multiple tube insertions (P=.02). Higher levels of TNF-{alpha} were noted in those children who subsequently developed episodes of otitis media after tube placement (P=.02). The ratio of TNF-{alpha} to TNFsolR, the mean (±SEM) inhibitor index, was 430±220 U.

Conclusions
Our data support the hypothesis that cytokines and their inhibitors are present in a large number of middle ear effusions and in part are likely important in the regulation of inflammatory processes in COME.

Arch Otolaryngol Head Neck Surg. 1997;123:984-988



Author Affiliations

From the Departments of Surgery and Surgical Research Center (Drs Maxwell, Leonard, and Kreutzer) and Pathology (Dr Kreutzer), University of Connecticut Health Center, Farmington.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.